DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy

Journal Article · · OncoImmunology (Online)
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1]; ORCiD logo [2]
  1. Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, China
  2. Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, China, College of Life Science, Zhengzhou University, Zhengzhou, Henan, China, Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, Henan, China

Not Available

Sponsoring Organization:
USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research
OSTI ID:
2229957
Journal Information:
OncoImmunology (Online), Journal Name: OncoImmunology (Online) Journal Issue: 1 Vol. 13; ISSN 2162-402X
Publisher:
Informa UK LimitedCopyright Statement
Country of Publication:
United Kingdom
Language:
English

References (41)

Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms journal May 2020
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma journal February 2019
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer journal January 2021
Actin cytoskeletal dynamics in T lymphocyte activation and migration journal January 2003
Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer journal April 2018
The role of the integrin LFA‐1 in T‐lymphocyte migration journal July 2007
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2 journal April 2022
Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata journal September 2022
BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway journal January 2013
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor journal January 2021
NgR1 is an NK cell inhibitory receptor that destabilizes the immunological synapse journal January 2023
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade journal December 2016
Capping the hydroxyl groups (-OH) of α-cellulose to reduce Hy-groscopicity for accurate 18O/16O measurement by EA/Py/IRMS journal September 2023
Intracellular signalling controlling integrin activation in lymphocytes journal June 2005
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade journal July 2022
IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein journal December 2022
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer journal December 2022
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial journal February 2023
IL-2 and IL-7 Induce Heterodimerization of STAT5 Isoforms in Human Peripheral Blood T Lymphoblasts journal November 1997
Magnesium sensing via LFA-1 regulates CD8+ T cell effector function journal February 2022
Role of LFA-1 integrin in the control of a lymphocytic choriomeningitis virus (LCMV) infection journal November 2020
Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer journal June 2017
IL-2: The First Effective Immunotherapy for Human Cancer journal June 2014
Chemokines and integrins independently tune actin flow and substrate friction during intranodal migration of T cells journal May 2018
LFA-1 in T cell priming, differentiation, and effector functions journal August 2021
The JAK/STAT signaling pathway: from bench to clinic journal November 2021
‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses journal May 2022
Interleukin-2: Inception, Impact, and Implications journal May 1988
Immune synapse formation determines interaction forces between T cells and antigen-presenting cells measured by atomic force microscopy journal October 2009
Ectocytosis renders T cell receptor signaling self-limiting at the immune synapse journal May 2023
IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model journal February 2023
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy journal March 2021
Mechanically active integrins target lytic secretion at the immune synapse to facilitate cellular cytotoxicity journal June 2022
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade journal June 2018
Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy journal February 2021
Tumour-Infiltrating Lymphocytes and Interleukin-2 in Treatment of Advanced Cancer journal March 1989
STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus journal October 2017
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy journal August 2020
Signaling and Function of Interleukin-2 in T Lymphocytes journal April 2018
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients journal June 2011
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages journal January 2023